A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel

Patients with recurrent or refractory head and neck squamous cell carcinoma received cisplatin/epinephrine injectable gel or placebo gel injected directly into the clinically dominant tumour. The double-blind phase III trial comprised of up to 6 weekly treatments over 8 weeks, 4 weekly evaluation vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, J A, Kehrl, W, Pluzanska, A, Arndt, O, Lavery, K M, Glaholm, J, Dietz, A, Dyckhoff, G, Maune, S, Stewart, M E, Orenberg, E K, Leavitt, R D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364322/
https://www.ncbi.nlm.nih.gov/pubmed/12434280
http://dx.doi.org/10.1038/sj.bjc.6600588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364322/
https://www.ncbi.nlm.nih.gov/pubmed/12434280
http://dx.doi.org/10.1038/sj.bjc.6600588

Ejemplares similares